The project will bring in 29 institutions from North America, Europe and India and will use privacy-preserved data to train AI models. Federated learning has been described as being born at the intersection of AI, blockchain, edge computing and the Internet of Things.
Digital health companies have raised large funding rounds, but have struggled to make major traction with physicians and patients. Executives with Johnson & Johnson and Intel shared what they see as the path to a solution.
Large pharma companies are partnering with tech firms to use artificial intelligence and machine learning to speed up drug discovery.
"We're trying to turn the key in the brain that changes motivations," said Maureen Glynn, senior director of research and compliance for Care Innovations.
Neurodegenerative diseases represent a particularly interesting area for wearables to come into play as research scientists seek to better understand disease progression.
The Broad Institute plans to develop and roll out GATK4, the next generation version of Genome Analysis Toolkit. The new service will include cancer, structural variation, copy number variation and related functionality.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Much like Intel's new Collaborative Cancer Cloud, several precision medicine partnerships are springing up around the country. Here are six more.
Matthew Quinn has served as the director of healthcare initiatives for the Federal Communications Commission for the past year, but as of this Monday he returns to the private sector. He will be Intel’s East Coast managing director for healthcare and life sciences . That’s setting up an interesting perspective for another upcoming role — […]
A PhD student has created a makerspace at a children's hospital in Tennessee to bring STEM education to sick kids and let them build a better hospital room.
He’s only 15, but Intel International Science and Engineering Fair winner Nathan Han may be on his way to making some important advances in cancer research. His winning invention is a machine-learning software tool he’s been using to examine in detail the characteristics of several mutations of the BRCA1 gene, which produces tumor suppressor proteins. […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Utah’s Intermountain Health is hoping that collaborating will equal innovation with new efforts to bring medical advancements to the bedside quicker and more efficiently. The nonprofit health system has recruited technology heavyweights Intel and computer architecture company Xi3 Corp. as founding partners in its new Healthcare Transformation Lab. Located on the premises of its flagship […]
Dr. Mark Blatt, the worldwide medical director at Intel, envisions a future where doctors can "see" twice as many patients in a day for a fraction of what it costs today. But seeing doesn't necessarily mean seeing in-person.
Pancreatic cancer has a reputation as the silent killer because it frequently isn’t diagnosed until after it has metastasized, and there is currently no reliable way to detect it. But a 15-year-old entrepreneur in the making has developed an early detection device with 90 percent accuracy, a noninvasive tool that could improve chances of survival […]
One of the biggest storyies in the National Football League this season revolves around concussions resulting from horrific hits on the field. Last week, chip maker Intel Corp. said it's researching the topic, partnering with universities and a major helmet manufacturer to develop computer simulations that can assess the risk of head injuries. Key to Intel's efforts is a collaboration with Mayo Clinic.
Patients will measure their vital signs such as blood pressure, pulse and weight, and respond to questions related to their diseases on a daily basis. A clinical care team will review the data, and will be able to use videoconferencing to further evaluate the patients.
